MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States

    NEXT STORY
    Checkpoint Therapeutics Announces Confirmation of Registration Path for Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
    PREV STORY
    Recombinant Vaccines Market to Reach $21 Billion by 2026; Increasing Number of Regulatory Approvals to Aid Growth, says Fortune Business Insights™
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Cultures Approaches 40 Percent

    author_avatar
    NASDAQ Market News

    LGC Capital Announces Agreement to Acquire a Significant Interest in Fully Licenced European Pharmaceutical Company, Freia Farmaceutici Srl.

    author_avatar
    NASDAQ Market News

    A second abstract accepted at ISOBM in Hamburg demonstrating enhanced diagnostic value when using AroCell’s proprietary sample preparation method

    AroCell AB announces today that a second abstract has been accepted by ISOBM (International ...

    author_avatar
    NASDAQ Market News